[et_pb_section fb_built=”1″ admin_label=”Home 2 Content Pg” _builder_version=”4.16″ _module_preset=”default” background_color=”#bbe4ed” background_image=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-header-engagement-1000×200-1.jpg” background_size=”initial” width_phone=”auto” width_last_edited=”off|desktop” max_width_last_edited=”off|desktop” module_alignment=”center” min_height_tablet=”300px” min_height_last_edited=”off|desktop” height=”200px” height_tablet=”154px” height_phone=”100px” height_last_edited=”on|phone” max_height_tablet=”300px” max_height_phone=”300px” max_height_last_edited=”off|desktop” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” top_divider_height_tablet=”” top_divider_height_phone=”50px” top_divider_height_last_edited=”on|phone” bottom_divider_style=”curve” bottom_divider_color=”#FFFFFF” bottom_divider_height=”70px” bottom_divider_arrangement=”above_content” bottom_divider_height_tablet=”70px” bottom_divider_height_phone=”50px” bottom_divider_height_last_edited=”on|desktop” background_last_edited=”on|tablet” background_image_phone=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-mobile-stars.jpg” background_enable_image_phone=”on” parallax_tablet=”off” parallax_phone=”off” background_size_tablet=”contain” background_size_phone=”initial” background_position_tablet=”top_center” background_position_phone=”top_right” background_enable_video_mp4_tablet=”off” background_enable_video_mp4_phone=”off” module_alignment_tablet=”right” module_alignment_phone=”left” module_alignment_last_edited=”off|desktop” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.16″ _module_preset=”default” module_alignment=”center” custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text content_tablet=”<\/p>\n
” content_phone=”<\/p>\n
” content_last_edited=”on|phone” _builder_version=”4.27.0″ _module_preset=”default” z_index=”10″ custom_margin=”30px||||false|false” custom_margin_tablet=”30px||||false|false” custom_margin_phone=”|0%|||false|false” custom_margin_last_edited=”on|phone” custom_padding=”|187px|||false|false” custom_padding_tablet=”|427px|||false|false” custom_padding_phone=”|0px|||false|false” custom_padding_last_edited=”on|desktop” hover_enabled=”0″ locked=”off” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_enable_color=”off” custom_margin=”20px||21px||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”tsc” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”40px||40px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.20.2″ _module_preset=”default” custom_padding=”0px|0px|9px|0px|false|false” locked=”off” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/logo-tsa-400×371-1.png” alt=”TSC Alliance Logo” title_text=”logo-tsa-400×371″ url=”https:\/\/www.tscalliance.org\/” url_new_window=”on” _builder_version=”4.16″ _module_preset=”2aac2a59-5def-488a-9341-6b77093333c2″ max_width=”50%” max_width_tablet=”25%” max_width_phone=”50%” max_width_last_edited=”on|desktop” module_alignment=”center” module_alignment_tablet=”left” module_alignment_phone=”left” module_alignment_last_edited=”on|desktop” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The TSC Alliance aims to find a cure while also improving the quality of life for those affected by Tuberous Sclerosis Complex. Their vision is delivered through support of accelerating research, improving access and quality of care, providing support to families, educating, and strengthening the TSC community. <\/p>\n
LEARN MORE ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”mda” _builder_version=”4.19.2″ _module_preset=”default” background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”2px||2px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”2px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\n CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Mustafa Sahin MD, PhD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT05059327 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Mustafa Sahin MD, PhD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT05104983 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Mustafa Sahin MD, PhD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT03363763 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Mustafa Sahin MD, PhD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT02849457 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Jurriaan Peters, MD, PhD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT04285346 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Mustafa Sahin MD, PhD\u00a0 |\u00a0 Natural History Study \u2014 NCT02461459 ><\/a> For PatientsPartnership for Tuberous Sclerosis Complex (TSC)TSC Alliance The TSC Alliance aims to find a cure while also improving the quality of life for those affected by Tuberous Sclerosis Complex. Their vision is delivered through support of accelerating research, improving access and quality of care, providing support to families, educating, and strengthening the TSC community. […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":8782,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-11215","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/comments?post=11215"}],"version-history":[{"count":4,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11215\/revisions"}],"predecessor-version":[{"id":12212,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11215\/revisions\/12212"}],"up":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/media?parent=11215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Basimglurant in Children and Adolescents With TSC<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nStopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study (TSC-STEPS)<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nTopical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nPreventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nAdjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (TSC)<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nAutism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)<\/h3>\n
\nPatient Advocacy Group Partner: TSC Alliance<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"